Eir Diagnostic is a biomedical engineering company developing a diagnostic platform for rapid detection of almost any bacteria, viruses or biomarkers from living systems. Our technology is unique.
The Eir Diagnostic’s system comprises a disposable biosensor chip and reader device. We are working on finishing the chip development and validating the platform with detection of a very specific biomarker proteins.
The company is currently funded by a range of private investors and works also under government funded InnoBooster program. However, we are always open to talk to interested financial or strategic investors.
For any questions concerning investor relations, please contact CEO Michael Døssing
Phone +45 2815 1905 Mail: email@example.com
Copyright © Eir Diagnostics 2020